A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

NCT00890981 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Bone Mass
Low Bone Mineral Density
Osteoporosis
Postmenopausal Osteoporosis

Interventions

PROCEDURE: high-resolution peripheral quantitative computed tomography (HR-pQCT)
PROCEDURE: Dual energy X-ray absorptiometry (DXA)
BIOLOGICAL: Denosumab
DRUG: Placebo

Sponsor

Amgen